MOSCOW (MRC) -- Mitsubishi Chemical Corporation has announced plans to establish a new production site for performance polymers in Chengdu, Sichuan Province, China, and start production of PVC slush powder, which is suitable for automotive interior panel skins and other parts, in the spring of 2019, as per the company's press release.
Currently, MCC has two production sites for performance polymers in Suzhou and Changshu, located in Jiangsu Province in coastal China, and produces PVC compounds including PVC slush powder, thermoplastic elastomer, and adhesive polyolefin, for various applications such as automobiles, electric wires and cables, and construction materials.
The automotive market of performance polymers in China has shown a steady expansion, and expectations are especially high for the future growth in demand for PVC compounds including PVC slush powder, which have excellent design capabilities and texture, for use in automotive interiors. MCC aims to meet this robust demand by establishing a new performance polymer production site, through a newly-established subsidiary in Chengdu, in west-central China, where automotive parts production sites have clustered in recent years.
The company also plans to look into production of items for the food, medical care, and optical fields, which, like performance polymers, are expected to see significant growth in the future.
MCC will continue to enhance its performance polymers business through diversifying its application portfolio and accelerating business development in growth markets.
As MRC wrote before, in December 2017, Ube Industries, JSR Corp. and Mitsubishi Chemical Corp. (MCC) received European Commission (EC) approval for the planned integration of their acrylonitrile butadiene styrene (ABS) subsidiaries.
Mitsubishi Chemical with headquarters in Tokyo, Japan, is a diversified chemical company involved in petrochemicals, polymers, agrochemicals, speciality chemicals and pharmaceuticals. The company's main focus is on three business pillars: petrochemicals, performance and functional products, and health care.
MRC